Japan to Purchase 150 Million Doses of Novavax COVID-19 Vaccine

Novavax, a Rockville, Maryland company, Md., on April 28, 2009. Paul J. Richards/AFP via Getty Images

Japan has agreed to purchase 150 million doses of the Takeda-produced Novavax COVID-19 vaccine, the drugmaker announced on Tuesday.

The pharmaceutical company and Japan’s biggest drugmaker said in a statement that it is preparing to manufacture the Novavax COVID-19 vaccine domestically for distribution beginning early next year, pending approval from regulators.